ArticleCureus2026
Management of Advanced Tricompartmental Knee Osteoarthritis With Degenerative Meniscal Pathology Using Extracorporeal Magnetotransduction Therapy, Extracorporeal Shockwave Therapy, Microfragmented Adipose Tissue, and Platelet-Rich Plasma.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Advanced tricompartmental knee osteoarthritis (OA) with degenerative meniscal tears and ligamentous insufficiency represents a considerably difficult presentation in non-surgical musculoskeletal medicine. Although total knee arthroplasty is the current standard for surgical intervention, many patients may prefer to first explore non-surgical options or may require interim symptom management prior to surgery. This report describes management of a complex case of advanced knee OA via a staged non-surgical protocol utilizing extracorporeal shockwave therapy (ESWT), extracorporeal magnetotransduction therapy (EMTT), and a combined microfragmented adipose tissue (MFAT) and platelet-rich plasma (PRP) procedure in a 68-year-old female. The Knee Injury and Osteoarthritis Outcome Score (KOOS) and Numeric Rating Scale (NRS) were used to track patient progress and pain throughout treatment and post-procedure follow-ups. The KOOS is a patient-reported outcome measure consisting of five subscales in its entirety: pain, symptoms, activities of daily living, recreation function, and quality of life (QOL). For the purposes of tracking our outcomes in this specific case, we determined that only the pain, symptoms, and QOL subscales were relevant to the real-world outcomes of this patient. The NRS is an 11-point patient-reported pain scale ranging from 0 to 10. The patient showed a reduction in NRS pain scores and overall improvement in KOOS domains of pain, symptoms, and QOL. Biologic joint preservation using MFAT and PRP with mechanotransductive priming produced clinically meaningful improvement in advanced knee OA, warranting consideration as a bridge or alternative to arthroplasty in appropriate patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.